menu
    • menu

    Company profile for Tricida, Inc

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational drug candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive m...
    Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational drug candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tricida, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7000 Shoreline Court, Suite 201 South San Francisco, CA 94080
    Telephone
    Telephone
    (415) 429-7800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tricida.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/tricida-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tricida files for Chapter 11 bankruptcy protection as it searches for a buyer
    Tricida files for Chapter 11 bankruptcy protection as it searches for a buyer

    13 Jan 2023

    // PROACTIVE INVESTORS

    https://www.proactiveinvestors.com/companies/news/1003175/tricida-files-for-chapter-11-bankruptcy-protection-as-it-searches-for-a-buyer-1003175.html

    PROACTIVE INVESTORS
    13 Jan 2023
    Share Share
    Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave
    Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave

    15 Nov 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/adamis-harpoon-neoleukin-and-tricida-add-biotech-layoff-wave-pipeline-setbacks-spur-cuts

    Nick Paul Taylor FIERCEBIOTECH
    15 Nov 2022
    Share Share
    Tricida Announces Third Quarter 2022 Financial Results
    Tricida Announces Third Quarter 2022 Financial Results

    14 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221114005800/en

    BUSINESSWIRE
    14 Nov 2022
    Share Share
    Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
    Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager

    03 Nov 2022

    // Paul Schloesser ENDPTS

    https://endpts.com/tricida-eyeing-sale-cost-cutting-options-after-failing-high-stakes-ckd-wager/

    Paul Schloesser ENDPTS
    03 Nov 2022
    Share Share
    Tricida Provides Strategic Update
    Tricida Provides Strategic Update

    02 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221102006072/en

    BUSINESSWIRE
    02 Nov 2022
    Share Share
    Phase 3 fail seals fate of Tricida's FDA-rejected kidney drug
    Phase 3 fail seals fate of Tricida's FDA-rejected kidney drug

    25 Oct 2022

    // James Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/tricidas-shares-plunge-phase-3-fail-seals-fate-fda-rejected-kidney-drug

    James Waldron FIERCEBIOTECH
    25 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search